Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Toludesvenlafaxine vs Venlafaxine in Major Depression Disorder
NCT06278038Completed
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Feb 2024
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of toludesvenlafaxine in major depressive disorder (MDD) (2 arms), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoint: Snaith-Hamilton Pleasure Scale Total Score at Week 8. Started Feb 2024; status: completed.
02
Drugs
toludesvenlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT06278038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06278038.